Edwards Lifesciences Corporation Interest Expense
Edwards Lifesciences Corporation (EW) reported Interest Expense of $17.60 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-12.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-02-12
- Edwards Lifesciences Corporation interest expense for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation interest expense for the quarter ending 2017-12-31 was $19.30M, a 56.91% increase year-over-year.
- Edwards Lifesciences Corporation interest expense for the quarter ending 2017-09-30 was $100.00K, a 95.24% decline year-over-year.
- Edwards Lifesciences Corporation interest expense for the quarter ending 2017-06-30 was $1.40M, a 41.67% decline year-over-year.
- Edwards Lifesciences Corporation interest expense for fiscal 2023 was $17.60M, a 8.33% decline from fiscal 2022.
- Edwards Lifesciences Corporation interest expense for fiscal 2022 was $19.20M, a 4.35% increase from fiscal 2021.
- Edwards Lifesciences Corporation interest expense for fiscal 2021 was $18.40M, a 16.46% increase from fiscal 2020.
- Edwards Lifesciences Corporation interest expense for fiscal 2020 was $15.80M, a 23.67% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $17.60M 10-K · filed 2024-02-12 | |||
| 2022-12-31 | $19.20M 10-K · filed 2024-02-12 | |||
| 2021-12-31 | $18.40M 10-K · filed 2024-02-12 | |||
| 2020-12-31 | $15.80M 10-K · filed 2023-02-13 | |||
| 2019-12-31 | $20.70M 10-K · filed 2022-02-14 | |||
| 2018-12-31 | $29.90M 10-K · filed 2021-02-12 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-07-27 | $800.00K 10-Q · filed 2018-07-27 | ||
| 2017-12-31 | $19.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $19.40M derived: sum of 2 quarters · filed 2020-02-14 | $20.80M derived: sum of 3 quarters · filed 2020-02-14 | $23.20M 10-K · filed 2020-02-14 |
| 2017-09-30 | $100.00K 10-Q · filed 2017-10-27 | $1.50M derived: sum of 2 quarters · filed 2017-10-27 | $3.90M 10-Q · filed 2017-10-27 | $16.20M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $1.40M 10-Q · filed 2017-07-28 | $3.80M 10-Q · filed 2017-07-28 | $16.10M derived: sum of 3 quarters · filed 2019-02-15 | $18.20M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $2.40M 10-Q · filed 2017-04-28 | $14.70M derived: sum of 2 quarters · filed 2019-02-15 | $16.80M derived: sum of 3 quarters · filed 2019-02-15 | $19.20M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $12.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $14.40M derived: sum of 2 quarters · filed 2019-02-15 | $16.80M derived: sum of 3 quarters · filed 2019-02-15 | $19.20M 10-K · filed 2019-02-15 |
| 2016-09-30 | $2.10M 10-Q · filed 2017-10-27 | $4.50M derived: sum of 2 quarters · filed 2017-10-27 | $6.90M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $2.40M 10-Q · filed 2017-07-28 | $4.80M 10-Q · filed 2017-07-28 | ||
| 2016-03-31 | $2.40M 10-Q · filed 2017-04-28 | |||
| 2015-12-31 | $17.20M 10-K · filed 2018-02-16 | |||
| 2014-12-31 | $17.20M 10-K · filed 2017-02-17 | |||
| 2013-12-31 | $9.80M 10-K · filed 2016-02-19 | |||
| 2012-12-31 | $4.40M 10-K · filed 2015-02-20 | |||
| 2011-12-31 | $3.10M 10-K · filed 2014-02-28 | |||
| 2010-12-31 | $2.40M 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $2.70M 10-K · filed 2012-02-27 | |||
| 2008-12-31 | $7.20M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |